Fuling-Guizhi Herb Pair in Coronary Heart Disease: Integrating Network Pharmacology and In Vivo Pharmacological Evaluation

Table 1

A list of the active compounds in FGHP.

No.	Compound	OB (%)	DL	Herb
1	(2R)-2-[(3S, 5R, 10S, 13R, 14R, 16R, 17R)-3,16-Dihydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-enoic acid	30.93	0.81	FL
2	Trametenolic acid	38.71	0.8	FL
3	Cerevisterol	37.96	0.77	FL
4	Ergosterol peroxide	40.36	0.81	FL
5	3β-Hydroxy-24-methylene-8-lanostene-21-oic acid	38.7	0.81	FL
6	Pachymic acid	33.63	0.81	FL
7	Poricoic acid A	30.61	0.76	FL
8	Poricoic acid B	30.52	0.75	FL
9	Poricoic acid C	38.15	0.75	FL
10	Hederagenin	36.91	0.75	FL
11	Dehydroeburicoic acid	44.17	0.83	FL
12	(−)-Taxifolin	60.51	0.27	GZ
13	β-Sitosterol	36.91	0.75	GZ
14	Sitosterol	36.91	0.75	GZ
15	(+)-Catechin	54.83	0.24	GZ
16	ent-Epicatechin	48.96	0.24	GZ
17	Taxifolin	57.84	0.27	GZ
18	Peroxyergosterol	44.39	0.82	GZ